Ghent University Academic Bibliography

Journal Article
A1
open access

Metabolomics reveals alterations in gut-derived uremic toxins and tryptophan metabolism in feline chronic kidney disease

Laurens Van Mulders (UGent) , Ellen Vanden Broecke (UGent) , Ellen De Paepe (UGent) , Femke Mortier, Lynn Vanhaecke (UGent) and Sylvie Daminet (UGent)

(2025) VETERINARY QUARTERLY. 45(1). p.1-15

Add to list

Journal Article
A1
open access

Revitalizing the gut microbiome in chronic kidney disease : a comprehensive exploration of the therapeutic potential of physical activity

Marieke Vandecruys, Stefan De Smet, Jasmine De Beir (UGent) , Marie Renier, Sofie Leunis, Hanne Van Criekinge, Griet Glorieux (UGent) , Jeroen Raes, Karsten Vanden Wyngaert (UGent) , Evi Nagler (UGent) , et al.

(2024) TOXINS. 16(6).

Add to list

Journal Article
A1
open access

Isolation and quantification of uremic toxin precursor-generating gut bacteria in chronic kidney disease patients

Tessa Gryp, Geert R. B. Huys, Marie Joossens (UGent) , Wim Van Biesen (UGent) , Griet Glorieux (UGent) and Mario Vaneechoutte (UGent)

(2020) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 21(6).

Add to list

Journal Article
A1
open access

Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease see

Tessa Gryp, Kim De Paepe (UGent) , Raymond Vanholder (UGent) , Frederiek-Maarten Kerckhof (UGent) , Wim Van Biesen (UGent) , Tom Van de Wiele (UGent) , Francis Verbeke (UGent) , Marijn Speeckaert (UGent) , Marie Joossens, Marie Madeleine Couttenye, et al.

(2020) KIDNEY INTERNATIONAL. 97(6). p.1230-1242

Add to list

Journal Article
A1
open access

Biochemical and clinical impact of organic uremic retention solutes : a comprehensive update

Raymond Vanholder (UGent) , Anneleen Pletinck, Eva Schepers (UGent) and Griet Glorieux (UGent)

(2018) TOXINS. 10(1).

Add to list

Lipid management in patients with chronic kidney disease

Charles J Ferro, Patrick B Mark, Mehmet Kanbay, Pantelis Sarafidis, Gunnar H Heine, Patrick Rossignol, Ziad A Massy, Francesca Mallamaoi, Jose M Valdivielso, Jolanta Malyszko, et al.

(2018) NATURE REVIEWS NEPHROLOGY. 14(12). p.727-749

Add to list

Urea and chronic kidney disease : the comeback of the century? (in uraemia research)

Raymond Vanholder (UGent) , Tessa Gryp and Griet Glorieux (UGent)

(2018) NEPHROLOGY DIALYSIS TRANSPLANTATION. 33(1). p.4-12

Add to list

Early and asymptomatic cardiac dysfunction in chronic kidney disease

Shanmugakumar Chinnappa, Edward Chite, Nigel Lewis, Omer Baldo, Yu-Kang Tu, Griet Glorieux (UGent) , Raymond Vanholder (UGent) , Meguid El Nahas and Andrew Mooney

(2018) NEPHROLOGY DIALYSIS TRANSPLANTATION. 33(3). p.450-458

Add to list

Therapeutic efficacy and safety of ACE inhibitors in the hypertensive paediatric population : a review

Evelien Snauwaert (UGent) , Johan Vande Walle (UGent) and Pauline De Bruyne (UGent)

(2017) ARCHIVES OF DISEASE IN CHILDHOOD. 102(1). p.63-71

Add to list

Clinical practice recommendations for treatment with active vitamin D analogues in children with chronic kidney disease stages 2-5 and on dialysis

Rukshana Shroff, Mandy Wan, Evi Nagler (UGent) , Sevcan Bakkaloğlu, Mario Cozzolino, Justine Bacchetta, Alberto Edefonti, Constantinos J Stefanidis, Johan Vande Walle (UGent) , Gema Ariceta, et al.

(2017) NEPHROLOGY DIALYSIS TRANSPLANTATION. 32(7). p.1114-1127

Academic Bibliography

Metabolomics reveals alterations in gut-derived uremic toxins and tryptophan metabolism in feline chronic kidney disease

Revitalizing the gut microbiome in chronic kidney disease : a comprehensive exploration of the therapeutic potential of physical activity

Isolation and quantification of uremic toxin precursor-generating gut bacteria in chronic kidney disease patients

Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease see

Biochemical and clinical impact of organic uremic retention solutes : a comprehensive update

Lipid management in patients with chronic kidney disease

Urea and chronic kidney disease : the comeback of the century? (in uraemia research)

Early and asymptomatic cardiac dysfunction in chronic kidney disease

Therapeutic efficacy and safety of ACE inhibitors in the hypertensive paediatric population : a review

Clinical practice recommendations for treatment with active vitamin D analogues in children with chronic kidney disease stages 2-5 and on dialysis

Contents

Support

Contact